FAM
FBRX icon

Fred Alger Management’s Forte Biosciences FBRX Stock Holding History

Fred Alger Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33M Sell
1,273,965
-187,006
-13% -$5.39M 0.14% 78
2025
Q4 		$39.8M Sell
1,460,971
-175,059
-11% -$3.07M 0.16% 74
2025
Q3 		$24.5M Buy
1,636,030
+17,381
+1% +$200K 0.1% 110
2025
Q2 		$20.9M Buy
1,618,649
+708,040
+78% +$6.09M 0.09% 117
2025
Q1 		$7.07M Sell
910,609
-223,335
-20% -$2.64M 0.04% 192
2024
Q4 		$25.8M Buy
1,133,944
+1,051,246
+1,271% +$12.5M 0.12% 111
2024
Q3 		$462K Buy
82,698
+9,139
+12% +$94K ﹤0.01% 381
2024
Q2 		$988K Hold
73,559
– – ﹤0.01% 359
2024
Q1 		$1.28M Hold
73,559
– – 0.01% 363
2023
Q4 		$1.51M Hold
73,559
– – 0.01% 348
2023
Q3 		$1.22M Buy
+73,559
New +$1.63M 0.01% 352
2021
Q3 		– Sell
-48,701
Closed -$40.9M – 531
2021
Q2 		$40.9M Buy
48,701
+26,417
+119% +$23.8M 0.1% 172
2021
Q1 		$19.1M Buy
22,284
+2,963
+15% +$2.43M 0.05% 206
2020
Q4 		$17.6M Buy
19,321
+688
+4% +$647K 0.05% 202
2020
Q3 		$22.6M Sell
18,633
-10,333
-36% -$6.85M 0.07% 159
2020
Q2 		$10.6M Buy
+28,966
New +$12.9M 0.03% 184

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fred Alger Management's FBRX Position: Q1 2026 in Review

Fred Alger Management reduced its Forte Biosciences (FBRX) stake by 13% in Q1 2026, selling an estimated $5.39M and leaving 1,273,965 shares worth $33M. The position accounts for 0.14% of the portfolio, ranked #78.

Fred Alger Management first reported a position in FBRX in Q2 2020 and has held it in 16 quarters since. The position peaked at $40.9M in Q2 2021. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Fred Alger Management held 1,273,965 shares of Forte Biosciences worth $33M as of Q1 2026.
  • Fred Alger Management sold 187,006 Forte Biosciences shares in Q1 2026, an estimated $5.39M.
  • Forte Biosciences made up 0.14% of Fred Alger Management's portfolio in Q1 2026, its #78 holding.
  • Fred Alger Management first reported a position in Forte Biosciences in Q2 2020 and has held it in 16 quarters since.
  • Fred Alger Management's Forte Biosciences position peaked at $40.9M in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.